Category:David Spiegel of New Haven CT (US)

David Spiegel of New Haven CT (US)

Executive Summary

David Spiegel of New Haven CT (US) is an inventor who has filed 5 patents. Their primary areas of innovation include the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds (4 patents), Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca (4 patents), PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (3 patents), and they have worked with companies such as YALE UNIVERSITY (4 patents), Yale University (1 patents). Their most frequent collaborators include (2 collaborations), (2 collaborations), (1 collaborations).

Patent Filing Activity

Technology Areas

List of Technology Areas

• A61K47/55 (the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds): 4 patents
• A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 4 patents
• A61K47/545 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 3 patents
• A61K47/60 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 patents
• A61K47/549 ({Sugars, nucleosides, nucleotides or nucleic acids}): 2 patents
• C07D249/04 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 2 patents
• A61K47/65 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61P25/00 (Drugs for disorders of the nervous system): 1 patents
• C07K16/44 (PEPTIDES (peptides in foodstuffs): 1 patents
• A61K9/0019 (Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations): 1 patents
• A61K31/4192 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K47/54 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K47/646 ({the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines}): 1 patents
• A61K47/68 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K47/6803 ({Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates}): 1 patents
• A61K47/6869 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K47/6873 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K47/6891 ({Pre-targeting systems involving an antibody for targeting specific cells}): 1 patents
• C07K16/3069 (PEPTIDES (peptides in foodstuffs): 1 patents
• C07K2317/31 (PEPTIDES (peptides in foodstuffs): 1 patents
• C07D413/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
• C07H15/26 (SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids): 1 patents
• A61K47/64 (Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers): 1 patents

Companies

List of Companies

• YALE UNIVERSITY: 4 patents
• Yale University: 1 patents

Collaborators

• Rebecca Howell of New Haven CT (US) (2 collaborations)
• David McDonald of New Haven CT (US) (2 collaborations)
• David Caianiello of New Haven CT (US) (1 collaborations)
• Ryan Murelli of Belleville NJ (US) (1 collaborations)
• Andrew Zhang of Waltham MA (US) (1 collaborations)
• David CAIANIELLO of New Haven CT (US) (1 collaborations)